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SUMMARY  1 
Background Higher grip strength is associated with a better health outcomes. The optimal 2 
way to report grip strength (i.e. absolute vs. relative) for prediction, however, remains to be 3 
established.  4 
Methods In participants (aged 40-69 at baseline) from the UK Biobank, we examined the 5 
associations of grip strength, expressed in absolute terms (kilograms) and relative to 6 
anthropometric variables, with mortality and disease incidence, after exclusion of the first 2 7 
years of follow up, and compared risk predictions scores of handgrip strength when 8 
differentially expressed.  9 
Results Of the 356 721 participants included in the analysis 6234 died (1.7%) and 4523 10 
developed CVD (1.3%) over a mean follow-up of 5.0 years (ranging from 3.3 to 7.8) for 11 
mortality and 4.1 years (ranging from 2.4 to 7.0) for disease incidence data. As expected, 12 
baseline higher grip strength was associated with lower risk of all-cause and cause specific 13 
mortality and incidence. These associations did not meaningfully differ when grip-strength was 14 
expressed in absolute terms, vs. relative to height, weight, fat-free mass, BMI, fat-free mass 15 
index and fat-free mass, or as z-scores. Similarly the different ways of expressing grip strength 16 
had little effect on the ability of grip strength to improve risk prediction, based on C-index 17 
change, of an office-based risk score.  18 
Conclusions The ability of grip strength to predict mortality is not altered by changing how it 19 
is expressed.  20 
Keywords: handgrip strength, mortality, CVD, cancer, prediction 21 
Key messages:  22 
• The association of grip strength with a variety of health outcomes does not differ when 23 
express as z-scores or relative to anthropometric variables 24 
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• Similarly the predictive ability of grip strength does not differ when changing how it is 1 
expressed  2 
• For clinical utility grip strength can simply be expressed in absolute units (kg)  3 
5 
 
Introduction 1 
On top of its functional role in allowing body movement, skeletal muscle is also the primary 2 
protein store within the body and the primary tissues for glucose disposal, and thus has an 3 
important role in health and disease [1,2]. Several studies have shown that lower muscle 4 
function is associated with an increase in mortality and morbidity risk [3,4,5,6,7,8,9]. Indeed in 5 
our recent paper analysing data from 477 074 participants (aged 40-70 years) from the UK 6 
Biobank study we found that low grip strength was associated with an increased risk for all-7 
cause, cardiovascular, cancer and respiratory disease mortality [10]. Furthermore, we found 8 
that the addition of handgrip strength to an office-based risk score, including age, sex, 9 
diabetes, body mass index, systolic blood pressure and smoking, improved all-cause and 10 
cardiovascular mortality risk prediction. Together these data indicate that the measurement of 11 
grip strength may have clinical utility in risk screening.  12 
 13 
Currently, however, the measurement and reporting of grip strength data is not standardised 14 
[11], which not only presents issues with its use in research studies but also in clinical settings. 15 
For example, although the majority of reference ranges [12,13,14] and suggested clinical cut-16 
off values for definition of sarcopenia and weakness [15] are given with handgrip strength 17 
measured in kilograms it is known that handgrip strength varies, not only by sex and age, but 18 
by anthropometric characteristics such as height, body mass, body mass index and fat free 19 
mass. Whether the expression of grip strength in relative, rather than absolute, terms improves 20 
the association of hand grip strength with mortality/morbidity remains to be established. 21 
Furthermore whether the expression of grip strength in relative terms improves the predictive 22 
ability of handgrip strength over pre-existing risk score has yet to be investigated.  23 
 24 
The aims of this study, therefore, were to investigate the associations of grip strength, 25 
expressed 1) in absolute terms (kilograms) and 2) relative to anthropometric variables, with 26 
mortality and disease incidence and to compare risk prediction scores of handgrip strength 27 
when differentially expressed.  28 
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Methods 1 
Between April 2007 and December 2010, UK Biobank recruited >502 000 participants, aged 2 
40-70 years from the general population [16]. Participants attended one of 22 assessment 3 
centres across England, Wales and Scotland [17,18] where they completed a touch-screen 4 
questionnaire, had physical measurements taken and provided biological samples, as 5 
described in detail elsewhere [17,18]. The outcomes in the current study were all cause 6 
mortality, and incidence and mortality of cancer, cardiovascular (CVD), and respiratory  7 
diseases, with the exposure variable being grip strength (both absolute and relative to 8 
anthropometric variables). Socio-demographic factors (age, sex, ethnicity and area-based 9 
socioeconomic status), month of recruitment, smoking status, height, body mass index, 10 
systolic blood pressure, medications for CVD, self-reported physical activity time and dietary 11 
intake were treated as potential confounders. Participants with the following prevalent 12 
morbidities at recruitment were excluded from analysis: alcohol related disorders, atrial 13 
fibrillation, cancer, coronary heart disease, bipolar disorder, chronic obstructive pulmonary 14 
disease, chronic liver disease, dementia, depression, diabetes, eating disorder, heart failure, 15 
inflammatory bowel disease, schizophrenia, substance related disorders, stroke.  16 
Procedures 17 
Date of death and date and cause of hospital admissions were identified as described 18 
previously [19]. Grip strength was measured  as previously described [19] and the mean of 19 
the right and left values was calculated and expressed in absolute units (kg) and relative to 20 
height (cm), weight (kg), fat-free mass (kg), BMI (kg/m2), fat-free mass index (kg/m2) and fat-21 
free mass (%) for subsequent analysis. Handgrip strength z-scores were also calculated and 22 
used in analysis (based on normative British data [25]). Physical activity was based on self-23 
report, using the International Physical Activity Questionnaire short form [20], and total time 24 
spent in sedentary behaviours was derived from the sum of self-reported time spent driving, 25 
using a computer and watching television.  26 
8 
 
The frequency of intake of food items was collected using a touchscreen questionnaire. Area-1 
based socioeconomic status was derived from postcode of residence, using the Townsend 2 
score [21]. Age was calculated from dates of birth and baseline assessment. Smoking status 3 
was categorised into never, former and current smoking. Medical history and medications for 4 
CVD were collected from the self-completed, baseline assessment questionnaire. Height, 5 
body weight, and blood pressure were measured by trained nurses during the initial 6 
assessment centre visit. Body mass index (BMI) was calculated as (weight/height2) and the 7 
WHO criteria used to classify BMI into: underweight <18.5, normal weight: 18.5 to<25, 8 
overweight: 25 to<30, obese: 30 to <35, obesity class 2: 35 to <40 and obesity class 3: ≥40 9 
kg.m-2. Body composition (body fat and fat free mass) were measured using bio-impedance 10 
by trained nurses. Further details of these measurements can be found in the UK Biobank 11 
online protocol (http://www.ukbiobank.ac.uk). 12 
 13 
Statistical analyses 14 
Non-linear associations between grip strength and health outcomes were visually explored 15 
using multivariable penalised cubic splines in Cox-proportional hazard models [22] . Penalised 16 
spline is a technique to balance between data fit and smoothness [23]. Spline curvature is 17 
penalised by the integrated second derivative. Knots were selected based on generalised 18 
cross validation (GCV) and were equally spaced across the range of the exposure variable. 19 
Spline values were restricted to be linear below the first and beyond the final knots to ensure 20 
numerical stability [24]. The results were reported as hazard ratios together with 95% 21 
confidence intervals.  22 
Eight representations of grip strength were analysed: 1) absolute grip strength in kg, 2) age- 23 
and sex-specific grip strength z-score based on a national reference [25], and 3) grip strength 24 
divided by height, weight, fat-free mass, BMI, fat-free mass index (fat-free mass ÷ squared 25 
height in metre) and fat-free mass proportion (fat-free mass ÷ weight). All these variables, 26 
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except for the z-score, were standardised against their mean and standard deviation of the 1 
whole sample ([X – MeanX] ÷ SDX) for comparison.  2 
Cox proportional hazard analyses were adjusted for socio-demographic recruitment 3 
covariates (age, sex, ethnicity, Townsend deprivation index and month of recruitment), 4 
smoking status, systolic blood pressure, medications for CVD, self-reported physical activity 5 
time and dietary intake. Participants with prevalent morbidity at baseline as above) were 6 
excluded from the analysis to minimise reverse causation. All the analyses were performed 7 
with the exclusion of events in the first two years (two-year landmark).  8 
To compare the predictive ability of handgrip strength indicators, we calculated Harrell’s C-9 
index (which estimates the probability of concordance between observed and predicted 10 
responses) [26] for a model including office-based risk factors including age, sex, diabetes 11 
diagnosed, BMI (per 5 kg.m-2), systolic blood pressure (per 10 mmHg) and smokers, and then 12 
compared the ability to predict all-cause mortality, as described elsewhere [10]. To validate 13 
the predictive ability of grip strength, a bootstrap validation (500 bootstrap samples of the 14 
analysed sample size [n = 356 721]) was conducted. C-indices of training (data used to 15 
estimate the model) and testing (data not used to estimate the model) data are reported. 16 
Bootstrapping is a non-parametric resampling technique to estimate the accuracy of prediction 17 
methods [27].    18 
The proportional hazard assumption was checked by tests based on Schöenfeld residuals. All 19 
analyses were performed using R statistical software (version 3.5.1) with packages survival 20 
and rms. 21 
  22 
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Results 1 
Of the 502 628 participants recruited to UK Biobank, 134 587 (26.8%) had prevalent 2 
morbidities at recruitment and were excluded. Among the remaining 368 041 participants, 11 3 
320 (3.1%) had missing grip strength, implausible height (<1.4 m), BMI (<10 or >50), fat-free 4 
mass index, (<12.5 or >30) or fat-free mass proportion (<50% or >90%) and were therefore 5 
excluded, resulting in a final sample size of 356 721 participants for analysis. The mean follow-6 
up period for all-cause and CVD mortality was 5.0 years (ranging from 3.3 to 7.8) and 4.1 7 
years (ranging from 2.4 to 7.0) for disease incidence. Of those participants included in the 8 
respective analysis, over the follow up period 6234 died (1.7%) and 4523 developed CVD 9 
(1.3%). 10 
 11 
The main characteristics of the participants by quartiles of grip strength are summarised in 12 
Table 1. In summary, a higher grip strength is found in males and non-smokers, and those 13 
with higher height, BMI, fat-free mass, fat-free mass index, fat-free mass proportion, physical 14 
activity levels, and energy intake.  15 
 16 
Our data demonstrate that higher grip strength was associated with lower risk of all-cause, 17 
CVD, respiratory and cancer mortality (Figure 1 and Appendices 1, 3 and 5), and incident 18 
CVD, respiratory diseases and cancer (Figure 2 and Appendices 4 and 6). The association 19 
with all-cause mortality appeared to be an exponential decay pattern (pnonlinear = 0.002; Figure 20 
1). Similar association patterns were also observed for CVD mortality (Appendix 2) and 21 
incidence (Figure 2) and respiratory disease mortality and incidence (Appendices 3 and 4). 22 
On the other hand, associations with cancer mortality (pnonlinear = 0.29) and incidence (pnonlinear 23 
= 0.15) appear to be more linear (Appendices 5 and 6). Such association patterns were largely 24 
similar across different grip strength indicators, although a more linear relationship with 25 
incident CVD was seen when grip strength was expressed relative to weight and fat-free mass 26 
index (Figure 2). The association of grip strength relative to fat-free mass proportion appears 27 
to have a suggestive U-shape even though there are wide confidence intervals at the upper 28 
11 
 
end. These associations did not differ substantially between the minimally and 1 
comprehensively adjusted models (Data not shown) nor when comparing participants with and 2 
without co-morbidities (Data not shown). As detailed in Supplementary Table S1 when 3 
comparing Harrell’s C-indices to predict all-cause and cause-specific mortality between the 4 
different ways to express grip strength there was very little difference and even where relative 5 
expressions were somewhat numerically higher, these were not statistically significant (P > 6 
0.48).  7 
 8 
  9 
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Discussion 1 
The main finding of the current study is that when comparing numerous different ways to 2 
express grip strength, ie absolute, relative to height, weight, fat-free mass, BMI, fat-free mass 3 
index and z-scores, there is no difference in the association of grip strength with all-cause, 4 
CVD or cancer mortality. These findings could have important public health implications as 5 
they suggest that the simplest method to report the measurement of grip strength i.e. in 6 
absolute units (kg) is perfectly suitable for the prediction of health outcomes within clinical 7 
practice.  8 
 9 
The findings of an inverse association of grip strength with all-cause, CVD and cancer mortality 10 
is in line with the findings of previous studies [3,4,5,6,10,28]. Together these data provide 11 
strong evidence that the measurement of grip strength may have clinical utility in predicting 12 
an elevated risk of poorer subsequent health outcomes. Clearly, however, prior to potential 13 
implementation in clinical practice further work is needed to help guide how best to use grip 14 
strength to help with disease prediction. As grip strength is known to vary dependent on many 15 
factors which are routinely collected, such as height, body mass, body mass index and fat free 16 
mass, establishing the optimal way to express grip is a key step in this process. The current 17 
study found that the shape and magnitude of the associations of grip strength with health 18 
outcomes was not changed by expressing grip strength relative to these factors, nor by using 19 
z-scores.  20 
 21 
Additionally, when comparing the C-indices the predictive ability of grip strength did differed 22 
negligibly by the different methods to express grip strength. Indeed as we have shown 23 
previously [10] the addition of absolute grip strength to an office based risk score (age, sex, 24 
diabetes diagnosed, BMI, systolic blood pressure and smoking status) improved the C-index 25 
by 0.013. This magnitude of improvement is similar to that seen when adding high density 26 
lipoprotein cholesterol (C-index change 0.007) and N-terminal pro b-type natriuretic peptide 27 
(C-index change 0.020), for a composite outcome of coronary heart disease plus stroke and 28 
13 
 
heart failure, to conventional risk factor scores (age, sex, smoking, systolic blood pressure, 1 
history of diabetes, and concentration of total cholesterol) [29]. There was little difference in 2 
this improvement in C-indices when grip strength was expressed relatively or as a Z-score, 3 
and although the C-index was numerically higher when grip strength was expressed relative 4 
to height, weight and fat-free mass this was not significantly different nor likely to be of clinical 5 
significance (C-index increases of 0.0003 to 0.0017, above C-index for absolute grip strength). 6 
This would suggest, therefore, that when grip strength is implemented in clinical practice any 7 
of these ways to express grip strength would be valid, but that the use of absolute units (kg) 8 
may be the simplest way forward. 9 
 10 
Study limitations 11 
The UK Biobank is not representative of the UK general population in several ways. The UK 12 
Biobank is relatively representative of the general UK population in terms of age, sex, ethnicity 13 
and socioeconomic status but is only partially representative in terms of lifestyle. Therefore, 14 
caution should be heeded in generalizing  the results to the general population [30]. 15 
Participants were more likely to be older, women, live in less socioeconomically deprived 16 
areas and were less likely to be obese, smoke, drink alcohol on a daily basis and had fewer 17 
self-reported health outcomes. Rates of all-cause mortality and cancer incidence were also 18 
lower [16,30]. Reverse causality is possible in any observational study; and whilst our design 19 
excluded many comorbidities at baseline and results were similar after a landmark analysis of 20 
events occurring from 2 years after recruitment, we cannot fully exclude the potential of 21 
reverse causality. Similarly residual confounding is always possible and the associations 22 
observed may not imply causality. However, given that we are largely interested in prediction 23 
and identification of individuals at increased risk, and not seeking to make causal inferences, 24 
reverse causality is not a major limitation in this type of work.  25 
 26 
Conclusions 27 
14 
 
The ability of grip strength to predict all-cause mortality and other important disease 1 
outcomes appears not to be altered by changing how it is expressed.  This means that as 2 
grip strength in absolute values can predict health outcomes as well as the more complex 3 
ratios this may simplify the use of grip strength in both research and clinical practice for risk 4 
prediction. It is worth pointing out, however, that in practice the clinical interpretation of a grip 5 
strength score may be easiest using population derived z-scores, accounting for sex and 6 
age.  7 
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FIGURE LEGENDS 1 
Figure 1. Association between all-cause mortality and handgrip strength expressed in absolute and 2 
relative terms in fully adjusted models.   3 
 4 
Data is presented as hazard ratio and its 95%CI. Absolute and relative markers of handgrip strength 5 
were standarised against their mean and SD to allow comparison across diferent markers of handgrip 6 
strength. Analyses were conducted using a 2-year landmark analyses and participants with major 7 
comorbidities were excluded from the analyses (n=129,100). All analyses were adjusted for age, sex, 8 
ethnicity, Townsend deprivation index and month of recruitment); smoking status, systolic blood 9 
pressure, medications for CVD, self-reported physical activity time and dietary intake of red meat, 10 
processed meat, fruit and vegetables, and oily fish. HGS: handgrip strength.  11 
  12 
Figure 2. Association between incident CVD and handgrip strength expressed in absolute and relative 13 
terms in fully adjusted models. 14 
 15 
Data is presented as hazard ratio and its 95%CI. Absolute and relative markers of handgrip strength 16 
were standarised against their mean and SD to allow comparison across diferent markers of handgrip 17 
strength. Analyses were conducted using a 2-year landmark analyses and participants with major 18 
comorbidities were excluded from the analyses (n=129,100). All analyses were adjusted for age, sex, 19 
ethnicity, Townsend deprivation index and month of recruitment); smoking status, systolic blood 20 
pressure, medications for CVD, self-reported physical activity time and dietary intake of red meat, 21 
processed meat, fruit and vegetables, and oily fish. HGS: handgrip strength.    22 
 23 
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